LY4064809 [14C]-STX-478

· Scorpion Therapeutics (subsidiary of Eli Lilly and Company)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY4064809 [14C]-STX-478, covering 2025-05-25 to 2025-05-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY4064809 [14C]-STX-478 in Healthy Male Participants [Phase 1]